Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-18 Purchase | 2023-10-31 07:08 am | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. 10% Owner | 1,317,716 | $0 | $0 | 1,094,091 (Indirect) | View |
| 2020-03-11 Sale | 2020-03-16 5:00 pm | Advaxis Inc. | ADXS | APPEL RONI Director | 3,000 | $0.56796 | $1,704 | 10,476 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Exercise | 2024-03-06 07:13 am | 2023-11-17 N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner | 15,000,000 | $0 | 51,900,000 (Indirect) | View |
| 2024-02-07 Exercise | 2024-02-12 2:16 pm | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner | 27,847,159 | $0.4 | 105,571,313 (Indirect) | View |
| 2024-02-07 Tax Withholding | 2024-02-12 2:16 pm | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner | 5,294,486 | $1.2465 | 105,571,313 (Indirect) | View |
| 2024-02-07 Exercise | 2024-02-12 2:16 pm | 2023-11-17 2028-11-17 | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner | 27,847,159 | $0 | 105,571,313 (Indirect) | View |
Ownership | 2023-11-08 4:01 pm | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Cabilly Yuval Director | 0 | $0 | 1,298,639 (Indirect) | View |
| 2023-10-18 Other | 2023-10-23 06:43 am | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | aMoon Growth Fund Limited Partnership 10% Owner | 0 | $0 | 560,602 (Direct) | View |
Ownership(A) | 2023-09-29 06:10 am | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund GP Partners L.P. I.B.F. Management Ltd. 10% Owner | 0 | $0 | 621,253 (Indirect) | View |
Ownership | 2023-09-11 12:41 pm | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. 10% Owner | 0 | $0 | 621,253 (Indirect) | View |
Ownership | 2023-01-30 06:37 am | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | aMoon Growth Fund Limited Partnership Schindel Yair Chaim 10% Owner | 0 | $0 | 560,602 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:19 pm | N/A 2031-06-09 | Ayala Pharmaceuticals Inc. | ADXS | SIDRANSKY DAVID Director | 4,730 | $0 | 5,245 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:18 pm | N/A 2028-03-20 | Ayala Pharmaceuticals Inc. | ADXS | GOLDBERG MURRAY A Director | 7,963 | $0 | 7,963 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:17 pm | N/A 2030-08-17 | Ayala Pharmaceuticals Inc. | ADXS | Bisker-Leib Vered Director | 3,981 | $0 | 3,981 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:16 pm | N/A 2028-03-20 | Ayala Pharmaceuticals Inc. | ADXS | Spiegel Robert J. Director | 7,963 | $0 | 7,963 (Direct) | View |
Ownership | 2021-02-16 4:30 pm | N/A 2030-11-16 | Advaxis Inc. | ADXS | Gitelman Igor Chief Accounting Officer | 0 | $0 | 50,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | Henderson Molly Executive Vice President & CFO | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | Khleif Samir N Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | APPEL RONI Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | Berlin Kenneth A President and CEO | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | PATTON JAMES P Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | SIDRANSKY DAVID Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | BERMAN RICHARD J Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-05-04 Option Award | 2020-05-05 4:00 pm | N/A 2030-05-04 | Advaxis Inc. | ADXS | Gutierrez Andres Executive Vice President & CMO | 50,000 | $0 | 50,000 (Direct) | View |